mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Bexarotene |
FIMM |
pan-cancer |
AAC |
0.45 |
0.003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.005 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |